Profile | GDS5420 / 206139_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 423.54 | 64 |
GSM1296119 | B_lesional_pre-dose | 495.62 | 68 |
GSM1296076 | C_lesional_pre-dose | 509.45 | 69 |
GSM1296092 | D_lesional_pre-dose | 508.28 | 68 |
GSM1296103 | E_lesional_pre-dose | 328.92 | 61 |
GSM1296078 | F_lesional_pre-dose | 552.17 | 70 |
GSM1296107 | G_lesional_pre-dose | 421.04 | 65 |
GSM1296109 | H_lesional_pre-dose | 485.12 | 67 |
GSM1296080 | I_lesional_pre-dose | 458.41 | 66 |
GSM1296090 | J_lesional_pre-dose | 536.81 | 69 |
GSM1296074 | K_lesional_pre-dose | 566.04 | 71 |
GSM1296111 | L_lesional_pre-dose | 548.64 | 69 |
GSM1296099 | M_lesional_pre-dose | 426.56 | 65 |
GSM1296086 | O_lesional_pre-dose | 470.57 | 67 |
GSM1296117 | P_lesional_pre-dose | 483.51 | 67 |
GSM1296113 | Q_lesional_pre-dose | 491.76 | 67 |
GSM1296096 | R_lesional_pre-dose | 451.56 | 66 |
GSM1296105 | S_lesional_pre-dose | 288.87 | 58 |
GSM1296098 | T_lesional_pre-dose | 397.25 | 64 |
GSM1296101 | U_lesional_pre-dose | 359.17 | 62 |
GSM1296121 | V_lesional_pre-dose | 434.31 | 65 |
GSM1296088 | W_lesional_pre-dose | 508.85 | 68 |
GSM1296082 | X_lesional_pre-dose | 514.39 | 69 |
GSM1296115 | Y_lesional_pre-dose | 461.03 | 66 |
GSM1296084 | Z_lesional_pre-dose | 384.92 | 63 |
GSM1296072 | B_lesional_day8 | 489.59 | 67 |
GSM1296069 | L_lesional_day8 | 385.59 | 63 |
GSM1296071 | P_lesional_day8 | 409.92 | 63 |
GSM1296070 | Y_lesional_day8 | 484.83 | 67 |
GSM1296073 | V_lesional_day8 | 442.01 | 66 |
GSM1296034 | A_lesional_day15 | 366 | 61 |
GSM1296041 | G_lesional_day15 | 473.09 | 67 |
GSM1296035 | R_lesional_day15 | 456.36 | 66 |
GSM1296038 | U_lesional_day15 | 460.14 | 66 |
GSM1296047 | B_lesional_day15 | 449.4 | 66 |
GSM1296039 | E_lesional_day15 | 385.3 | 64 |
GSM1296042 | H_lesional_day15 | 439.83 | 65 |
GSM1296043 | L_lesional_day15 | 461.36 | 66 |
GSM1296037 | M_lesional_day15 | 368.62 | 62 |
GSM1296046 | P_lesional_day15 | 556.82 | 69 |
GSM1296044 | Q_lesional_day15 | 419.13 | 64 |
GSM1296045 | Y_lesional_day15 | 353.1 | 61 |
GSM1296025 | C_lesional_day15 | 503.6 | 68 |
GSM1296033 | D_lesional_day15 | 450.22 | 66 |
GSM1296027 | I_lesional_day15 | 431.58 | 66 |
GSM1296032 | J_lesional_day15 | 445.26 | 65 |
GSM1296024 | K_lesional_day15 | 629.65 | 72 |
GSM1296031 | W_lesional_day15 | 374.69 | 62 |
GSM1296028 | X_lesional_day15 | 365.72 | 62 |
GSM1296029 | Z_lesional_day15 | 405.95 | 64 |
GSM1296026 | F_lesional_day15 | 532.62 | 69 |
GSM1296030 | O_lesional_day15 | 361.47 | 63 |
GSM1296040 | S_lesional_day15 | 337.35 | 61 |
GSM1296036 | T_lesional_day15 | 421.3 | 64 |
GSM1296048 | V_lesional_day15 | 458.19 | 66 |
GSM1296059 | A_lesional_day43 | 361.36 | 62 |
GSM1296066 | G_lesional_day43 | 464.79 | 66 |
GSM1296060 | R_lesional_day43 | 442.45 | 65 |
GSM1296063 | U_lesional_day43 | 409.1 | 65 |
GSM1296064 | E_lesional_day43 | 400.12 | 65 |
GSM1296067 | H_lesional_day43 | 440.58 | 65 |
GSM1296062 | M_lesional_day43 | 426.93 | 64 |
GSM1296068 | Q_lesional_day43 | 494.36 | 67 |
GSM1296050 | C_lesional_day43 | 420.79 | 65 |
GSM1296057 | D_lesional_day43 | 467.77 | 66 |
GSM1296052 | I_lesional_day43 | 413.97 | 65 |
GSM1296054 | J_lesional_day43 | 385.61 | 63 |
GSM1296049 | K_lesional_day43 | 478.1 | 67 |
GSM1296055 | W_lesional_day43 | 374.73 | 62 |
GSM1296053 | X_lesional_day43 | 390.52 | 63 |
GSM1296058 | Z_lesional_day43 | 503.14 | 68 |
GSM1296051 | F_lesional_day43 | 358.67 | 63 |
GSM1296056 | O_lesional_day43 | 491.41 | 68 |
GSM1296065 | S_lesional_day43 | 419.76 | 65 |
GSM1296061 | T_lesional_day43 | 461.38 | 66 |
GSM1296095 | A_non-lesional_pre-dose | 352.38 | 62 |
GSM1296120 | B_non-lesional_pre-dose | 412.85 | 64 |
GSM1296077 | C_non-lesional_pre-dose | 402.57 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 391.13 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 364.58 | 62 |
GSM1296079 | F_non-lesional_pre-dose | 409.2 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 475.88 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 365.48 | 61 |
GSM1296081 | I_non-lesional_pre-dose | 357.1 | 62 |
GSM1296091 | J_non-lesional_pre-dose | 652.29 | 72 |
GSM1296075 | K_non-lesional_pre-dose | 423.05 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 461.71 | 66 |
GSM1296100 | M_non-lesional_pre-dose | 497.67 | 67 |
GSM1296087 | O_non-lesional_pre-dose | 434.6 | 66 |
GSM1296118 | P_non-lesional_pre-dose | 428.89 | 64 |
GSM1296114 | Q_non-lesional_pre-dose | 449.34 | 65 |
GSM1296097 | R_non-lesional_pre-dose | 332.35 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 395.85 | 63 |
GSM1296102 | U_non-lesional_pre-dose | 298.81 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 413.34 | 64 |
GSM1296089 | W_non-lesional_pre-dose | 378.83 | 62 |
GSM1296083 | X_non-lesional_pre-dose | 251.04 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 350.84 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 350.48 | 62 |